OpenLB
Open Library of Bioscience
Advanced Search
Health economics review
Oct 08, 2024;14 (1): 84.

Unleashing the potential: the imperative of political support for health technology assessment in Iran.

Aidin Aryankhesal, Meysam Behzadifar, Ahad Bakhtiari, Samad Azari, Masoud Behzadifar
Author Information
  1. Aidin Aryankhesal: Faculty of Medicine and Health Sciences, School of Health Sciences, University of East Anglia, Norwich, UK.
  2. Meysam Behzadifar: Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
  3. Ahad Bakhtiari: Health Equity Research Center (HERC), Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  4. Samad Azari: Hospital Management Research Center, Health Management Research Institute, University of Medical Sciences, Tehran, Iran.
  5. Masoud Behzadifar: Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. masoudbehzadifar@gmail.com. ORCID
PMID: 39378013 DOI: 10.1186/s13561-024-00563-x

Abstract

Health Technology Assessment (HTA) is essential for evidence-based healthcare decision-making, yet its integration into Iran's healthcare system faces political and logistical challenges. Despite HTA's potential to improve resource allocation, limited awareness, data gaps, and competing priorities hinder its implementation. This commentary emphasizes the need for political support, advocating capacity-building, collaboration, and alignment with long-term health policies. Leveraging international partnerships and monitoring outcomes can enhance HTA's role in improving healthcare in Iran and contributing to global health advancements.

Keywords

Evidence-based decision-making Health policy Health technology assessment Healthcare system Iran Political support

References

  1. Int J Technol Assess Health Care. 2017 Jan;33(3):360-364 [PMID: 28434423]
  2. F1000Res. 2020 May 14;9:364 [PMID: 32595957]
  3. Health Econ Rev. 2023 Apr 20;13(1):23 [PMID: 37079131]
  4. Cost Eff Resour Alloc. 2021 Jul 7;19(1):39 [PMID: 34233710]
  5. Health Policy. 2012 Dec;108(2-3):194-202 [PMID: 23093020]
  6. Med J Islam Repub Iran. 2016 Jan 26;30:321 [PMID: 27390691]
  7. PLoS One. 2023 Mar 30;18(3):e0283663 [PMID: 36996128]
  8. Int J Technol Assess Health Care. 2022 May 06;38(1):e44 [PMID: 35513309]
  9. Pathog Glob Health. 2023 Mar;117(2):104-119 [PMID: 35950264]
  10. Med J Islam Repub Iran. 2014 Dec 29;28:157 [PMID: 25695015]
  11. Int J Technol Assess Health Care. 2021 Jul 01;37(1):e72 [PMID: 34193326]
  12. Int J Technol Assess Health Care. 2020;36(1):34-39 [PMID: 31928553]
  13. Int J Technol Assess Health Care. 2021 Feb 05;37:e36 [PMID: 33541449]
  14. BMC Health Serv Res. 2017 Sep 8;17(1):632 [PMID: 28886740]
  15. Int J Technol Assess Health Care. 2015 Jan;31(3):154-65 [PMID: 26044729]
  16. Rev Saude Publica. 2021 Oct 25;55:64 [PMID: 34706040]
  17. Int J Technol Assess Health Care. 2021 Mar 22;37:e46 [PMID: 33745475]
  18. Biotechnol Law Rep. 2014 Dec 1;33(6):221-248 [PMID: 25538377]
  19. Int J Technol Assess Health Care. 2016 Jan;32(4):191-199 [PMID: 27766998]
  20. Int J Technol Assess Health Care. 2023 May 22;39(1):e29 [PMID: 37212049]
  21. J Health Polit Policy Law. 2000 Dec;25(6):1083-120 [PMID: 11142053]
  22. Global Health. 2020 Jul 8;16(1):58 [PMID: 32641066]
  23. Int J Health Policy Manag. 2020 Jan 01;9(1):27-33 [PMID: 31902192]
  24. Risk Manag Healthc Policy. 2021 Jun 28;14:2757-2770 [PMID: 34234591]
  25. Can J Cardiol. 2022 Feb;38(2):259-266 [PMID: 34461229]
  26. Eur J Health Law. 2020 May 07;27(3):274-289 [PMID: 33652403]
  27. Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):251-261 [PMID: 30696372]
  28. Int J Technol Assess Health Care. 2010 Jul;26(3):341-7 [PMID: 20584365]
  29. F1000Res. 2018 Jan 17;7:72 [PMID: 29904588]
  30. Iran J Public Health. 2013 Jan 01;42(Supple1):50-4 [PMID: 23865016]
  31. Iran J Med Sci. 2021 May;46(3):198-206 [PMID: 34083852]
  32. Res Involv Engagem. 2021 Jan 05;7(1):1 [PMID: 33402216]
  33. Int J Technol Assess Health Care. 2007 Summer;23(3):310-5 [PMID: 17579932]
  34. Value Health Reg Issues. 2021 May;24:187-192 [PMID: 33838558]
  35. Int J Technol Assess Health Care. 2023 Feb 23;39(1):e15 [PMID: 36815310]
  36. J Prev Med Hyg. 2023 May 16;64(1):E107-E117 [PMID: 37293450]
  37. Front Public Health. 2022 Oct 28;10:1010702 [PMID: 36388387]
  38. J Health Serv Res Policy. 2018 Apr;23(2):72-79 [PMID: 29624087]
  39. Health Res Policy Syst. 2024 Jan 15;22(1):11 [PMID: 38225573]
  40. Health Policy. 2010 May;95(2-3):174-84 [PMID: 20074829]
  41. F1000Res. 2018 Feb 28;7:245 [PMID: 29770210]
  42. Health Res Policy Syst. 2021 Feb 11;19(1):19 [PMID: 33573676]
  43. Int J Technol Assess Health Care. 2020 Jul 27;:1-5 [PMID: 32715993]
  44. Therapie. 2023 Jan-Feb;78(1):81-94 [PMID: 36464522]
  45. J Evid Based Med. 2015 Aug;8(3):161-4 [PMID: 26291523]
  46. Int J Environ Res Public Health. 2021 Nov 13;18(22): [PMID: 34831668]
  47. Health Res Policy Syst. 2018 Feb 22;16(1):15 [PMID: 29471838]
  48. Glob Health Action. 2018;11(1):1527556 [PMID: 30326795]
Letter

Word Cloud

Created with Highcharts 10.0.0HealthhealthcarepoliticalsupporthealthIrandecision-makingsystemHTA'stechnologyassessmentTechnologyAssessmentHTAessentialevidence-basedyetintegrationIran'sfaceslogisticalchallengesDespitepotentialimproveresourceallocationlimitedawarenessdatagapscompetingprioritieshinderimplementationcommentaryemphasizesneedadvocatingcapacity-buildingcollaborationalignmentlong-termpoliciesLeveraginginternationalpartnershipsmonitoringoutcomescanenhanceroleimprovingcontributingglobaladvancementsUnleashingpotential:imperativeEvidence-basedpolicyHealthcarePolitical

Similar Articles

Cited By